<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">Given its established role as a DMARD, HCQ is potentially useful to treat chikungunya-induced chronic arthritis. A randomized controlled trial evaluated HCQ for this purpose after acute chikungunya infection [
 <xref rid="bib33" ref-type="bibr">33</xref>]. However, as HCQ was not ‘repurposed’ as an antiviral agent, this trial was outside the scope of this review.
</p>
